Search Results1-20 of  24

  • 1 / 2
  • Hamamoto Yasuo ID: 9000242686144

    Articles in CiNii:1

    • Case series of preoperative triplet-regimen (docetaxel, CDDP and 5-fluorouracil) for borderline resectable T4 thoracic esophageal carcinoma (2013)
  • Hamamoto Yasuo ID: 9000329006677

    Articles in CiNii:1

    • Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study (2016)
  • Hamamoto Yasuo ID: 9000329006757

    Articles in CiNii:1

    • Randomized phase Ⅱ study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407) (2016)
  • Hamamoto Yasuo ID: 9000368922216

    Articles in CiNii:1

    • Inter-evaluator heterogeneity of clinical diagnosis for locally advanced esophageal squamous cell carcinoma (2017)
  • Hamamoto Yasuo ID: 9000389001796

    Articles in CiNii:1

    • Treatment selection for esophageal cancer : evaluation from a nationwide database (2018)
  • Hamamoto Yasuo ID: 9000390405160

    Articles in CiNii:1

    • Regional differences in advanced gastric cancer : exploratory analyses of the AVAGAST placebo arm (2018)
  • Hamamoto Yasuo ID: 9000401420820

    Articles in CiNii:1

    • A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2) (2019)
  • Hamamoto Yasuo ID: 9000406185125

    Articles in CiNii:1

    • Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial : a randomized phase Ⅲ clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer (2020)
  • Hamamoto Yasuo ID: 9000409014513

    Articles in CiNii:1

    • Achieving sequential therapy in advanced gastric cancer : the importance of appropriate patient management for the elderly and/or those with ascites (2020)
  • Hamamoto Yasuo ID: 9000409014734

    Articles in CiNii:1

    • A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2) : 2-year update data (2020)
  • Hamamoto Yasuo ID: 9000411378138

    Articles in CiNii:1

    • Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma : a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3) (2021)
  • Hamamoto Yasuo ID: 9000412564215

    Articles in CiNii:1

    • Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2) : 3-year update and outcome of treatment beyond progression with nivolumab (2021)
  • HAMAMOTO Yasuo ID: 9000000339168

    Articles in CiNii:5

    • A case of polymyositis with anti-Jo-1 antibody preceded by BOOP (1998)
    • A case of dermatomyositis associated with asymptomatic pneumomediastinum (1998)
    • A case of early superfical gallbladder carcinoma associated with suspiciously anomalous arrangement of the pancreaticobiliary ductal system (1998)
  • HAMAMOTO Yasuo ID: 9000001060551

    First Department of Internal Medicine, Sapporo Medical University (2003 from CiNii)

    Articles in CiNii:1

    • Endoscopic Observation of Tissue by Narrowband Illumination (2003)
  • HAMAMOTO Yasuo ID: 9000001538458

    Department of Internal Medicine (Section I), Sapporo Medical University School of Medicine (2004 from CiNii)

    Articles in CiNii:1

    • A Case of Systemic Osteomyelitides Due to Mycobacterium avium (2004)
  • HAMAMOTO Yasuo ID: 9000014172239

    Division of Gastrointestinal Oncology and Digestive Endoscopy, National Cancer Center Hospital East (2008 from CiNii)

    Articles in CiNii:1

    • Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan : a retrospective review of 48 patients with metastatic colorectal cancer (2008)
  • HAMAMOTO Yasuo ID: 9000019061745

    Department of Medical Oncology, Tochigi Cancer Center (2011 from CiNii)

    Articles in CiNii:1

    • Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma (2011)
  • HAMAMOTO Yasuo ID: 9000238239235

    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine (2012 from CiNii)

    Articles in CiNii:1

    • Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA) : accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype (2012)
  • HAMAMOTO Yasuo ID: 9000243881906

    Keio Cancer Center, School of Medicine, Keio University (2014 from CiNii)

    Articles in CiNii:1

    • Current perspective of treatment for advanced esophageal squamous cell carcinoma (2014)
  • HAMAMOTO Yasuo ID: 9000391598967

    II surgical department of the Okayama University Medical School (1959 from CiNii)

    Articles in CiNii:1

    • Experimental studies on the circulatory disturbance of the lower colon due to the ligation of A. mesenterica caudalis:Part I The effects of ligation of the A. mesenterica caudalis and its branches on the blood supply of the lower colon in rabbit (1959)
  • 1 / 2
Page Top